The DOI matches its Crossref record; 106 of the 106 references it cites were found in a registry or an index.
Hallmarks of Cancer-Related Newly Prognostic Factors of Oral Squamous Cell Carcinoma
Open accessAbstract
Head and neck cancer, including oral squamous cell carcinoma (OSCC), is the sixth leading malignancy worldwide. OSCC is an aggressive tumor and its prognosis has exhibited little improvement in the last three decades. Comprehensive elucidation of OSCC’s molecular mechanism is imperative for early detection and treatment, improving patient survival. Based on broadly accepted notions, OSCC arises from multiple genetic alterations caused by chronic exposure to carcinogens. In 2011, research revealed 10 key alterations fundamental to cancer cell development: sustaining proliferative signaling, evading growth suppressors, avoiding immune destruction, activating invasion and metastasis, tumor-promoting inflammation, enabling replicative immortality, inducing angiogenesis, genome instability and mutation, resisting cell death, and deregulating energetics. This review describes molecular pathological findings on conventional and novel hallmarks of OSCC prognostic factors. In addition, the review summarizes the functions and roles of several molecules as novel OSCC prognosticators.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED ARTICLE: FOXC2 promotes colorectal cancer metastasis by directly targeting MET
Cui, Y.-M., Jiao, H.-L., Ye, Y.-P., Chen, C.-M., Wang, J.-X., Tang, N., Li, T.-T., Lin, J., Qi, L., Wu, P., et al. (2014) · Oncogene · doi:10.1038/onc.2014.368 · Cited by 82
RetractedHallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Global cancer statistics, 2012
Torre, L. A., Bray, F., Siegel, R. L., Ferlay, J., Lortet‐Tieulent, J., & Jemal, A. (2015) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21262 · Cited by 26,850
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
Ferris, R. L., Blumenschein, G., Fayette, J., Guigay, J., Colevas, A. D., Licitra, L., Harrington, K., Kasper, S., Vokes, E. E., Even, C., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1602252 · Cited by 5,101
Comprehensive genomic characterization of head and neck squamous cell carcinomas
The Cancer Genome Atlas Network (2015) · Nature · doi:10.1038/nature14129 · Cited by 3,877
Apoptosis: A Target for Anticancer Therapy
Pfeffer, C., & Singh, A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020448 · Cited by 1,542
miR-126 Regulates Angiogenic Signaling and Vascular Integrity
Fish, J. E., Santoro, M. M., Morton, S. U., Yu, S., Yeh, R.-F., Wythe, J. D., Ivey, K. N., Bruneau, B. G., Stainier, D. Y. R., & Srivastava, D. (2008) · Developmental Cell · doi:10.1016/j.devcel.2008.07.008 · Cited by 1,515
Human cancer immunotherapy with antibodies to the PD-1 and PD-L1 pathway
Ohaegbulam, K. C., Assal, A., Lazar-Molnar, E., Yao, Y., & Zang, X. (2015) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2014.10.009 · Cited by 843
Lu, J., Tan, M., & Cai, Q. (2015) · Cancer Letters · doi:10.1016/j.canlet.2014.04.001 · Cited by 795
Smith, J. J., Deane, N. G., Wu, F., Merchant, N. B., Zhang, B., Jiang, A., Lu, P., Johnson, J. C., Schmidt, C., Bailey, C. E., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2009.11.005 · Cited by 716
Molecular Pathogenesis of Oral Squamous Cell Carcinoma: Implications for Therapy
Choi, S., & Myers, J. N. (2008) · Journal of Dental Research · doi:10.1177/154405910808700104 · Cited by 516
He, J., Hu, Y., Hu, M., & Li, B. (2015) · Scientific Reports · doi:10.1038/srep13110 · Cited by 401
Oncogenic cancer/testis antigens: prime candidates for immunotherapy
Gjerstorff, M. F., Andersen, M. H., & Ditzel, H. J. (2015) · Oncotarget · doi:10.18632/oncotarget.4694 · Cited by 320
Antagonists of PD-1 and PD-L1 in Cancer Treatment
Lipson, E. J., Forde, P. M., Hammers, H.-J., Emens, L. A., Taube, J. M., & Topalian, S. L. (2015) · Seminars in Oncology · doi:10.1053/j.seminoncol.2015.05.013 · Cited by 306
WU, Y., ZHANG, L., ZHANG, L., WANG, Y., LI, H., REN, X., WEI, F., YU, W., LIU, T., WANG, X., et al. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.2976 · Cited by 262
Tumor angiogenesis and anti‑angiogenic gene therapy for cancer (Review)
Li, T., Kang, G., Wang, T., & Huang, H. (2018) · Oncology Letters · doi:10.3892/ol.2018.8733 · Cited by 240
Zhou, X., Liu, S., Cai, G., Kong, L., Zhang, T., Ren, Y., Wu, Y., Mei, M., Zhang, L., & Wang, X. (2015) · Scientific Reports · doi:10.1038/srep15972 · Cited by 228
Wang, J., Ye, C., Chen, C., Xiong, H., Xie, B., Zhou, J., Chen, Y., Zheng, S., & Wang, L. (2017) · Oncotarget · doi:10.18632/oncotarget.15171 · Cited by 205
Sasahira, T., Kurihara, M., Bhawal, U. K., Ueda, N., Shimomoto, T., Yamamoto, K., Kirita, T., & Kuniyasu, H. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.330 · Cited by 199
Self-citationMatsuyama, H., Suzuki, H. I., Nishimori, H., Noguchi, M., Yao, T., Komatsu, N., Mano, H., Sugimoto, K., & Miyazono, K. (2011) · Blood · doi:10.1182/blood-2011-05-354654 · Cited by 182
Transcription factor PROX1: its role in development and cancer
Elsir, T., Smits, A., Lindström, M. S., & Nistér, M. (2012) · Cancer and Metastasis Reviews · doi:10.1007/s10555-012-9390-8 · Cited by 160
Nakayama, A., Nakaoka, H., Yamamoto, K., Sakiyama, M., Shaukat, A., Toyoda, Y., Okada, Y., Kamatani, Y., Nakamura, T., Takada, T., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-209632 · Cited by 160
Neskey, D. M., Osman, A. A., Ow, T. J., Katsonis, P., McDonald, T., Hicks, S. C., Hsu, T.-K., Pickering, C. R., Ward, A., Patel, A., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-2735 · Cited by 158
ME1 Regulates NADPH Homeostasis to Promote Gastric Cancer Growth and Metastasis
Lu, Y., Ju, H., Liu, Z., Chen, D.-L., Wang, Y., Zhao, Q., Wu, Q.-N., Zeng, Z.-L., Qiu, H.-B., Hu, P.-S., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-3155 · Cited by 147
miR-375 Inhibits Differentiation of Neurites by Lowering HuD Levels
Abdelmohsen, K., Hutchison, E. R., Lee, E. K., Kuwano, Y., Kim, M. M., Masuda, K., Srikantan, S., Subaran, S. S., Marasa, B. S., Mattson, M. P., et al. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.00316-10 · Cited by 134
Kunkel, M., Moergel, M., Stockinger, M., Jeong, J., Fritz, G., Lehr, H., & Whiteside, T. L. (2007) · Oral Oncology · doi:10.1016/j.oraloncology.2006.10.009 · Cited by 124
Targeting EGF-receptor-signalling in squamous cell carcinomas of the head and neck
Reuter, C. W., Morgan, M. A., & Eckardt, A. M. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603566 · Cited by 113
Role of CDKN2A/p16 expression in the prognostication of oral squamous cell carcinoma
Padhi, S. S., Roy, S., Kar, M., Saha, A., Roy, S., Adhya, A. K., Baisakh, M. R., & Banerjee, B. (2017) · Oral Oncology · doi:10.1016/j.oraloncology.2017.07.030 · Cited by 112
Liang, X., Yang, D., Hu, J. R., Hao, X., Gao, J., & Mao, Z. (2008) · PubMed · Cited by 108
Prognostic significance of nuclear pSTAT3 in oral cancer
Macha, M. A., Matta, A., Kaur, J., Chauhan, S. S., Thakar, A., Shukla, N. K., Gupta, S. D., & Ralhan, R. (2010) · Head & Neck · doi:10.1002/hed.21468 · Cited by 105
Cai, J., Tian, A.-X., Wang, Q.-S., Kong, P.-Z., Du, X., Li, X., & Feng, Y.-M. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.07.001 · Cited by 104
Integrin α7 is a functional cancer stem cell surface marker in oesophageal squamous cell carcinoma
Ming, X.-Y., Fu, L., Zhang, L.-Y., Qin, Y.-R., Cao, T.-T., Chan, K. W., Ma, S., Xie, D., & Guan, X. (2016) · Nature Communications · doi:10.1038/ncomms13568 · Cited by 103
Jinno, T., Kawano, S., Maruse, Y., Matsubara, R., Goto, Y., Sakamoto, T., Hashiguchi, Y., Kaneko, N., Tanaka, H., Kitamura, R., et al. (2015) · Oncology Reports · doi:10.3892/or.2015.3838 · Cited by 94
Liu, Y., Ye, X., Zhang, J.-B., Ouyang, H., Shen, Z., Wu, Y., Wang, W., Wu, J., Tao, S., Yang, X., et al. (2015) · Oncogene · doi:10.1038/onc.2015.7 · Cited by 93
Osman, A. A., Neskey, D. M., Katsonis, P., Patel, A. A., Ward, A. M., Hsu, T., Hicks, S. C., McDonald, T. O., Ow, T. J., Alves, M. V. O., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-2729 · Cited by 92
Yu, C., Hung, S., Lin, H., Chiou, W., Lee, M., Liao, H., Huang, H., Ho, H.-C., & Su, Y. (2017) · Oncotarget · doi:10.18632/oncotarget.19817 · Cited by 92
Nagata, M., Nakayama, H., Tanaka, T., Yoshida, R., Yoshitake, Y., Fukuma, D., Kawahara, K., Nakagawa, Y., Ota, K., Hiraki, A., et al. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.387 · Cited by 90
Update of molecular pathobiology in oral cancer: a review
Sasahira, T., Kirita, T., & Kuniyasu, H. (2014) · International Journal of Clinical Oncology · doi:10.1007/s10147-014-0684-4 · Cited by 89
Self-citationMaruse, Y., Kawano, S., Jinno, T., Matsubara, R., Goto, Y., Kaneko, N., Sakamoto, T., Hashiguchi, Y., Moriyama, M., Toyoshima, T., et al. (2018) · International Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.ijom.2018.01.004 · Cited by 88
Liu, S., Liu, L., Ye, W., Ye, D., Wang, T., Guo, W., Liao, Y., Xu, D., Song, H., Zhang, L., et al. (2016) · Scientific Reports · doi:10.1038/srep38834 · Cited by 86
Camisasca, D. R., Honorato, J., Bernardo, V. G., et al. (2008) · Oral Oncology · doi:10.1016/j.oraloncology.2008.05.021 · Cited by 81
Fujita, Y., Okamoto, M., Goda, H., Tano, T., Nakashiro, K., Sugita, A., Fujita, T., Koido, S., Homma, S., Kawakami, Y., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110378 · Cited by 78
Foxc1 and Foxc2 deletion causes abnormal lymphangiogenesis and correlates with ERK hyperactivation
Fatima, A., Wang, Y., Uchida, Y., Norden, P. R., Liu, T., Culver, A. E., Dietz, W. H., Culver, F., Millay, M., Mukouyama, Y., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci80465 · Cited by 78
Wen, D., Liu, D., Tang, J., Dong, L., Liu, Y., Tao, Z., Wan, J.-L., Gao, D., Wang, L., Sun, H., et al. (2015) · Tumor Biology · doi:10.1007/s13277-015-3306-5 · Cited by 77
Troiano, G., Mastrangelo, F., Caponio, V. C. A., Laino, L., Cirillo, N., & Muzio, L. L. (2018) · Journal of Dental Research · doi:10.1177/0022034518762090 · Cited by 75
PROX1 Promotes Metabolic Adaptation and Fuels Outgrowth of Wnthigh Metastatic Colon Cancer Cells
Ragusa, S., Cheng, J., Ivanov, K. I., Zangger, N., Ceteci, F., Bernier‐Latmani, J., Milatos, S., Joseph, J., Tercier, S., Bouzourène, H., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.08.041 · Cited by 74
Miyazaki, T. (2011) · Oncology Reports · doi:10.3892/or.2011.1324 · Cited by 73
Prognostic value of glucosylceramide synthase and P-glycoprotein expression in oral cavity cancer
Kim, J. W., Park, Y., Roh, J., Cho, K., Choi, S. H., Nam, S. Y., & Kim, S. Y. (2016) · International Journal of Clinical Oncology · doi:10.1007/s10147-016-0973-1 · Cited by 71
Zhu, G., Tang, Y., Li, L., Zheng, M. H., Jiang, J. D., Li, X., Chen, S.-X., & Liang, X. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1408 · Cited by 68
Sasahira, T., Ueda, N., Yamamoto, K., Kurihara, M., Matsushima, S., BHAWAL, U. K., Kirita, T., & Kuniyasu, H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092534 · Cited by 66
Self-citationBasu, B., Chakraborty, J., Chandra, A., Katarkar, A., Baldevbhai, J., Chowdhury, D. D., Ray, J. G., Chaudhuri, K., & Chatterjee, R. (2017) · Clinical Epigenetics · doi:10.1186/s13148-017-0314-x · Cited by 65
Wang, W., Xu, D., Wang, B., Yan, S., Wang, X., Yin, Y., Wang, X., Sun, B., & Sun, X. (2015) · Mediators of Inflammation · doi:10.1155/2015/680853 · Cited by 63
Wang, F., Tidei, J. J., Polich, E. D., Gao, Y., Zhao, H., Perrone‐Bizzozero, N. I., Guo, W., & Zhao, X. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1513780112 · Cited by 62
PAUF functions in the metastasis of human pancreatic cancer cells and upregulates CXCR4 expression
Lee, Y., Kim, S.-H., Park, H., Park, E. H., Huang, S. M., Jeon, S. B., Kim, J.-M., Lim, D.-S., & Koh, S. S. (2009) · Oncogene · doi:10.1038/onc.2009.298 · Cited by 61
Li, H., Zheng, J., Fan, H., Li, H., Gao, Z., & Chen, D. (2013) · Journal of Oral Pathology and Medicine · doi:10.1111/jop.12044 · Cited by 58
Sasahira, T., Kirita, T., Kurihara, M., Yamamoto, K., BHAWAL, U. K., Bosserhoff, A., & Kuniyasu, H. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.04.027 · Cited by 56
Self-citationBui, N. Q., Huang, J. K.-L., Bojorquez-Gomez, A., Licon, K., Sanchez, K. S., Tang, S. N., Beckett, A., Wang, T., Zhang, W., Shen, J. P., et al. (2018) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-0937 · Cited by 54
MMP-11 promoted the oral cancer migration and FAK/Src activation
Hsin, C., Chou, Y., Yang, S., Su, S., Chuang, Y., Lin, S., & Lin, C. (2017) · Oncotarget · doi:10.18632/oncotarget.15824 · Cited by 53
Nakashima, C., Yamamoto, K., Fujiwara‐Tani, R., Luo, Y., Matsushima, S., Fujii, K., Ohmori, H., Sasahira, T., Sasaki, T., Kitadai, Y., et al. (2018) · Cancer Science · doi:10.1111/cas.13594 · Cited by 53
Self-citationChen, H.-H., Yu, C., Wang, J., Liu, B.-Y., Wang, Y., Sun, A., Tsai, T.-C., & Chiang, C. (2006) · Oral Oncology · doi:10.1016/j.oraloncology.2006.01.011 · Cited by 52
Chang, K., Wu, C., Fang, K., Tsai, C., Chang, Y., Liu, S.-C., & Kao, H. (2013) · Oral Oncology · doi:10.1016/j.oraloncology.2013.05.006 · Cited by 52
Hong, Y., He, H., Sui, W., Zhang, J., Zhang, S., & Yang, D. (2018) · International Journal of Oncology · doi:10.3892/ijo.2018.4247 · Cited by 51
Kurihara, Y., Hatori, M., Ando, Y., Ito, D., Toyoshima, T., Tanaka, M., & Shintani, S. (2009) · Clinical & Experimental Metastasis · doi:10.1007/s10585-009-9241-3 · Cited by 49
Vincent–Chong, V. K., Salahshourifar, I., Karen‐Ng, L. P., Siow, M. Y., Kallarakkal, T. G., Ramanathan, A., Yang, Y., Khor, G. H., Rahman, Z. A. A., Ismail, S. M., et al. (2014) · The Scientific World JOURNAL · doi:10.1155/2014/897523 · Cited by 47
Samaraweera, L., Grandinetti, K. B., Huang, R., Spengler, B. A., & Ross, R. A. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-309 · Cited by 46
Aberrant promoter methylation of PPP1R3C and EFHD1 in plasma of colorectal cancer patients
Takane, K., Midorikawa, Y., Yagi, K., Sakai, A., Aburatani, H., Takayama, T., & Kaneda, A. (2014) · Cancer Medicine · doi:10.1002/cam4.273 · Cited by 46
PROX1 and β-catenin are prognostic markers in pancreatic ductal adenocarcinoma
Saukkonen, K., Hagström, J., Mustonen, H. K., Juuti, A., Nordling, S., Kallio, P., Alitalo, K. K., Seppänen, H. E., & Haglund, C. H. (2016) · BMC Cancer · doi:10.1186/s12885-016-2497-5 · Cited by 46
Hypoxic condition and prognosis in oral squamous cell carcinoma.
de Lima, P. O., Jorge, C. C., Oliveira, D. T., & Pereira, M. C. (2014) · PubMed · Cited by 44
Silencing of GLUT ‐1 inhibits sensitization of oral cancer cells to cisplatin during hypoxia
Shimanishi, M., Ogi, K., Sogabe, Y., Kaneko, T., Dehari, H., Miyazaki, A., & Hiratsuka, H. (2012) · Journal of Oral Pathology and Medicine · doi:10.1111/jop.12028 · Cited by 44
Song, J., Lee, J., Kim, J., Jo, S., Kim, Y., Baek, J. E., Kwon, E., Lee, K., Yang, S., Kwon, K., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10123 · Cited by 41
Liu, Y., Zhang, Y., Wang, S., Dong, Q., Shen, Z., Wang, W., Tao, S., Gu, C., Liu, J., Xie, Y., et al. (2017) · Hepatology · doi:10.1002/hep.29337 · Cited by 41
Sj, K., Lee, Y., Kim, N. Y., Hwang, Y., Hwang, B. Y., Min, J.-K., & Koh, S. S. (2012) · Oncogene · doi:10.1038/onc.2012.366 · Cited by 40
Mingbin, Z., LI, J., Wang, L., Tian, Z., ZHANG, P., Xu, Q., Zhang, C., Wei, F., & Chen, W. (2013) · Oncology Letters · doi:10.3892/ol.2013.1381 · Cited by 39
PTEN: A potential prognostic marker in virus-induced hepatocellular carcinoma
Khalid, A., Hussain, T., Manzoor, S., Saalim, M., & Khaliq, S. (2017) · Tumor Biology · doi:10.1177/1010428317705754 · Cited by 39
MicroRNA-182 inhibits proliferation through targeting oncogenic ANUBL1 in gastric cancer
Tang, L., Chen, F., Pang, E., ZHANG, Z.-Q., Jin, B., & DONG, W.-F. (2015) · Oncology Reports · doi:10.3892/or.2015.3798 · Cited by 37
Apoptosis‐associated markers and clinical outcome in human oral squamous cell carcinomas
Kato, K., Kawashiri, S., Yoshizawa, K., Kitahara, H., & Yamamoto, E. (2008) · Journal of Oral Pathology and Medicine · doi:10.1111/j.1600-0714.2008.00642.x · Cited by 36
Murugan, A. K., Hồng, N. T., Cuc, T. T. K., Hung, N. C., Munirajan, A. K., Ikeda, M., & Tsuchida, N. (2009) · Oral Oncology · doi:10.1016/j.oraloncology.2009.05.638 · Cited by 36
Reduced expression of TANGO in colon and hepatocellular carcinomas
Arndt, S., & Bosserhoff, A. (2007) · Oncology Reports · doi:10.3892/or.18.4.885 · Cited by 33
Park, K.-J., Cho, S. B., Park, Y., Kim, N., Park, S.-Y., Myung, D., Lee, W., Kweon, S., & Joo, Y. (2016) · Gastric Cancer · doi:10.1007/s10120-015-0592-y · Cited by 33
Protumoral roles of melanoma inhibitory activity 2 in oral squamous cell carcinoma
Kurihara, M., Kirita, T., Sasahira, T., Ohmori, H., Matsushima, S., Yamamoto, K., Bosserhoff, A., & Kuniyasu, H. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.27 · Cited by 32
Self-citationBonfitto, V. L. L., Demasi, A. P. D., Costa, A. F., Bonfitto, J. F. L., de Araújo, V. C., & Altemani, A. (2010) · Journal of Clinical Pathology · doi:10.1136/jcp.2010.075390 · Cited by 32
Fenstad, M. H., Johnson, M. P., Løset, M., Mundal, S. B., Roten, L. T., Eide, I. P., Bjørge, L., Sande, R. K., Johansson, Å., Dyer, T. D., et al. (2010) · Molecular Human Reproduction · doi:10.1093/molehr/gaq064 · Cited by 32
Sasahira, T., Kurihara, M., Nakashima, C., Kirita, T., & Kuniyasu, H. (2016) · British Journal of Cancer · doi:10.1038/bjc.2016.167 · Cited by 32
Self-citationKalu, N. N., Mazumdar, T., Peng, S., Tong, P., Shen, L., Wang, J., Banerjee, U., Myers, J. N., Pickering, C. R., Brunell, D. J., et al. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.05.029 · Cited by 32
HuD Promotes Progression of Oral Squamous Cell Carcinoma
Sasahira, T., Kurihara, M., Yamamoto, K., Ueda, N., Nakashima, C., Matsushima, S., BHAWAL, U. K., Kirita, T., & Kuniyasu, H. (2014) · Pathobiology · doi:10.1159/000366022 · Cited by 30
Self-citationZhao, T., HU, F., Qiao, B., Chen, Z., & Tao, Q. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.2927 · Cited by 29
PROX1 Gene is Differentially Expressed in Oral Cancer and Reduces Cellular Proliferation
Rodrigues, M. F. S. D., Rodini, C. O., Xavier, F. C. D. A., Paiva, K. B. S., Severino, P., Moysés, R. A., López, R. M., Cicco, R. D., Rocha, L. A., de Carvalho, M. B., et al. (2014) · Medicine · doi:10.1097/md.0000000000000192 · Cited by 27
Kono, M., Watanabe, M., Abukawa, H., Hasegawa, O., Satomi, T., & Chikazu, D. (2013) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2013.04.015 · Cited by 27
Zhao, J., Chi, J., Gao, M., Zhi, J., Li, Y., & Zheng, X. (2017) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2017.03.025 · Cited by 27
Telomere dysfunction is related to the intrinsic radio-resistance of human oral cancer cells
McCaul, J. A., Gordon, K., Minty, F., Fleming, J., & Parkinson, E. K. (2007) · Oral Oncology · doi:10.1016/j.oraloncology.2007.02.010 · Cited by 26
Downregulation of CRNN gene and genomic instability at 1q21.3 in oral squamous cell carcinoma
Salahshourifar, I., Vincent–Chong, V. K., Chang, H., Ser, H., Ramanathan, A., Kallarakkal, T. G., Rahman, Z. A. A., Ismail, S. M., Prepageran, N., Mustafa, W. M. W., et al. (2015) · Clinical Oral Investigations · doi:10.1007/s00784-015-1467-7 · Cited by 24
Pu, Y., Wang, L., Wu, H., Feng, Z., Wang, Y., & Guo, C. (2014) · Oncology Reports · doi:10.3892/or.2014.3124 · Cited by 23
Phosphorylated EGFR at tyrosine 1173 correlates with poor prognosis in oral squamous cell carcinomas
Monteiro, L. S., Ricardo, S. A. V., Delgado, L., Garcez, F., do Amaral, B., & Lopes, C. (2013) · Oral Diseases · doi:10.1111/odi.12087 · Cited by 23
Telomeric repeat-binding factor 2: a marker for survival and anti-EGFR efficacy in oral carcinoma
Benhamou, Y., Picco, V., Raybaud, H., Sudaka, A., Chamorey, E., Brolih, S., Monteverde, M., Merlano, M. C., Nigro, C. L., Ambrosetti, D., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10005 · Cited by 23
Yokobori, T., Bao, P., Fukuchi, M., Altan, B., Ozawa, D., Rokudai, S., Bai, T., Kumakura, Y., Honjo, H., Hara, K., et al. (2015) · Annals of Surgical Oncology · doi:10.1245/s10434-015-4831-6 · Cited by 22
The telomere proteins in tumorigenesis and clinical outcomes of oral squamous cell carcinoma
Benhamou, Y., Picco, V., & Pagès, G. (2016) · Oral Oncology · doi:10.1016/j.oraloncology.2016.04.006 · Cited by 22
High PROX1 expression in gastric cancer predicts better survival
Laitinen, A., Böckelman, C., Hagström, J., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0183868 · Cited by 21
Panda, S., Padhiary, S. K., & Routray, S. (2016) · Oral Oncology · doi:10.1016/j.oraloncology.2016.06.008 · Cited by 20
da Silva, S. D., Alaoui‐Jamali, M. A., Hier, M., Soares, F. A., Graner, E., & Kowalski, L. P. (2013) · Clinical & Experimental Metastasis · doi:10.1007/s10585-013-9629-y · Cited by 19
Chen, C., Zhang, Y., Loomis, M. M., Upton, M. P., Lohavanichbutr, P., Houck, J. R., Doody, D. R., Méndez, E., Futran, N. D., Schwartz, S. M., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0135074 · Cited by 19
Jiang, T., Xie, P., & Liu, H. (2015) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2015.09.016 · Cited by 18
Storkhead box 2 and melanoma inhibitory activity promote oral squamous cell carcinoma progression
Sasahira, T., Nishiguchi, Y., Fujiwara, R., Kurihara, M., Kirita, T., Bosserhoff, A., & Kuniyasu, H. (2016) · Oncotarget · doi:10.18632/oncotarget.8495 · Cited by 18
Self-citationCui, L., Dang, S.-C., Qu, J.-G., Mao, Z., Wang, X., Zhang, J., & Chen, J. (2016) · Tumor Biology · doi:10.1007/s13277-015-4607-4 · Cited by 15
Application of Serum ELAVL4 (HuD) Antigen Assay for Small Cell Lung Cancer Diagnosis
WANG, F., LU, J., Li, S., Huo, X., Liu, X., Du, X., Li, C., Wang, J., & Chen, Z. (2017) · Anticancer Research · doi:10.21873/anticanres.11848 · Cited by 10
Cited by
Oral squamous cell carcinomas: state of the field and emerging directions
Tan, Y., Wang, Z., Xu, M., Li, B., Huang, Z., Qin, S., Nice, E. C., Tang, J., & Huang, C. (2023) · International Journal of Oral Science · doi:10.1038/s41368-023-00249-w · Cited by 831
Metadata
- Authors
- Sasahira, T., & Kirita, T.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2018-08-16
- Volume
- 19
- Issue
- 8
- Pages
- 2413
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W2887134879
- Cited by
- 275
- References
- 106
- FWCI
- 19.58
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.